In regards to corporate earnings, most investors focus their attention on sales and either net income or earnings per share (EPS). While sales figures are usually straightforward, EPS results are often reported in both GAAP (Generally Accepted Accounting Principles) and nonGAAP adjustments. GAAP results provide a standardized and consistent method to compare results, but do […]
Going into this year’s Analytica, the confidence level for a successful event was not particularly high, as signs of negativity seemed unmistakable. After all, talks of a recession in the US and the low dollar could deter many US-based companies from attending the show. The previous Analytica, which was two years ago (see IBO 4/30/06), […]
The EU is continuing its focus on maintaining its position as a top ranking R&D region. According to Eurostat, the UK, Germany and France were responsible for approximately 60% of total R&D expenditure in the EU in 2006. For that year, 1.84% of the EU’s GDP, €212 billion ($265 billion), was spent on R&D. The […]
The analytical and life science instrument industry has a new number one company. As a result of the acquisition of Fisher Scientific in November 2006 (see IBO 11/15/06), Thermo Fisher Scientific overtook Applied Biosystems in 2007 to become the world’s largest provider of analytical and life science instruments and aftermarket products, based on IBO’s calculations. […]
Fourth-quarter sales for the Lab Equipment/Consumables Index gained 9.8% to $865 million, while operating profits improved 15.7% to $243 million. Operating margin for the same period improved 150 basis points to 28.1% of sales. For the year, Index sales rose 11.0% to $3,284 million, operating profits increased 20.3% to $700 million and operating margin jumped […]
Bruker reported its full-year financial results following the publication of IBO’s quarterly sales issue (see IBO 2/29/08). The company also reported pro forma annual results that include Bruker BioSpin (see IBO 12/15/07), showing what to expect now that the companies have merged. Bruker’s fourth-quarter revenues grew 35.5%, 26% on a currency-neutral basis, to $183.7 million […]
This month, investors were left to weigh negative news involving liquidity issues in the financial markets after the collapse of Bear Sterns. At the same time, they had to consider the Federal Reserve’s 75 basis-point cut in interest rates on March 18 to 2.25%, which was designed to increase the availability of credit in the […]
Atomic Spectroscopy The Q4 Tasman is Bruker AXS’s latest introduction into the arc-spark spectrometer market. The system features a high-resolution CCD detector, making it fast and suitable for a wide range of general applications. The system should begin shipping by the end of March and is priced at approximately $90,000–$130,000. The S1 Tracer from Bruker […]
India continues to make significant investments in science and technology as evidenced by the government’s 2008–2009 budget proposal. The budget supports a 20.5% increase in funding for the Ministry of Science and Technology INR 3630.00 crore ($881.1 million = INR 41.20 = $1). The Ministry is one of the country’s primary funding mechanism for R&D. […]
New Orleans, Louisiana, played host to the 59th annual Pittsburgh conference and exhibition (Pittcon), which was held March 1–7 at the Ernest N. Morial Convention Center. Although Pittcon took place against a backdrop of escalating fears of a US recession, one would have never known it. Companies were upbeat about future business prospects and the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
